These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22577110)

  • 1. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up.
    Bo S; Gentile L; Castiglione A; Prandi V; Canil S; Ghigo E; Ciccone G
    Eur J Endocrinol; 2012 Aug; 167(2):173-80. PubMed ID: 22577110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register.
    Pikkemaat M; Melander O; Mölstad S; Garberg G; Boström KB
    Diabet Med; 2015 Jan; 32(1):85-9. PubMed ID: 25354243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between C peptide and chronic complications in type-2 diabetes mellitus.
    Sari R; Balci MK
    J Natl Med Assoc; 2005 Aug; 97(8):1113-8. PubMed ID: 16173326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
    Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
    Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
    Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
    Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA
    Metcalf PA; Kyle C; Kenealy T; Jackson RT
    J Diabetes Complications; 2017 May; 31(5):814-823. PubMed ID: 28319002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: a population-based cohort study in Italy.
    Cammarota S; Bruzzese D; Catapano AL; Citarella A; De Luca L; Manzoli L; Masulli M; Menditto E; Mezzetti A; Riegler S; Putignano D; Tragni E; Novellino E; Riccardi G
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):10-7. PubMed ID: 23806740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain.
    Mundet X; Pou A; Piquer N; Sanmartin MI; Tarruella M; Gimbert R; Farrus M
    Prim Care Diabetes; 2008 Sep; 2(3):135-40. PubMed ID: 18779037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus.
    Zoppini G; Negri C; Stoico V; Casati S; Pichiri I; Bonora E
    Metabolism; 2012 Jan; 61(1):22-9. PubMed ID: 21676418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
    Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Serum Markers of Oxidative Stress With Incident Major Cardiovascular Events, Cancer Incidence, and All-Cause Mortality in Type 2 Diabetes Patients: Pooled Results From Two Cohort Studies.
    Xuan Y; Gào X; Anusruti A; Holleczek B; Jansen EHJM; Muhlack DC; Brenner H; Schöttker B
    Diabetes Care; 2019 Aug; 42(8):1436-1445. PubMed ID: 31167893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.
    Hsu CN; Chang CH; Lin YS; Lin JW; Caffrey JL
    PLoS One; 2013; 8(2):e55625. PubMed ID: 23405181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study.
    Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R; Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G
    Dig Liver Dis; 2012 May; 44(5):406-12. PubMed ID: 22245505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.
    Zoppini G; Targher G; Chonchol M; Negri C; Stoico V; Pichiri I; Lippi G; Muggeo M; Bonora E
    Atherosclerosis; 2010 Jun; 210(2):575-80. PubMed ID: 20031129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.